Claritev (CTEV)

NYSEMarket Closed

Claritev Corporation is a healthcare technology, data, and analytics company serving participants in the United States healthcare system. The company’s work centers on a persistent challenge for insurers, employers, healthcare payers, and other clients: understanding medical claims, managing costs, improving payment accuracy, and creating greater transparency around healthcare pricing and reimbursement.

Claritev provides technology-enabled services that combine payment integrity, network-based capabilities, and analytics. Its solutions are designed to help clients review claims, identify billing or reimbursement issues, apply contractual and market-based pricing insights, and support end-to-end cost management. In a healthcare market known for complex billing practices and fragmented data, the company positions itself as an infrastructure partner that helps clients interpret information and make more consistent payment decisions.

The company’s offerings can support several related functions, including payment and revenue integrity, claims cost containment, data-driven decision support, and customized analytics. Rather than relying on a single product, Claritev works across multiple service categories and tailors solutions to client needs. That model reflects the varied requirements of health plans, third-party administrators, employers, and other organizations that face pressure to control medical spending while maintaining access to care.

Claritev operates in a sector shaped by rising healthcare costs, regulatory scrutiny, and increasing demand for transparent, data-supported pricing. Its value proposition depends on combining healthcare domain knowledge with scalable technology and large data assets. For investors, the company represents exposure to the administrative, analytics, and cost-management layer of the U.S. healthcare industry, rather than to direct care delivery or pharmaceutical innovation.

37.27USD
+3.19(+9.36%)

Last updated

Market Cap
$577,569,539
P/E
P/FCF
P/S
0.58
Enterprise Value
$5,335,754,539
Sector
Health Care
Industry
Health Care Equipment
Address
7900 TYSONS ONE PLACE, MCLEAN, VA, 22102
yahoo.com

UnitedHealth Group (UNH) Stock Still Looks Cheap Following Raised 2026 Outlook

18 Jul 2026, 03:08 AM
yahoo.com

UnitedHealth Group (UNH) Faces Wider DOJ Antitrust Probe As Claritev Review Expands

15 Jul 2026, 00:15 AM
yahoo.com

Update: Market Chatter: DOJ Expands Antitrust Probe Into Claritev

14 Jul 2026, 19:53 PM
globenewswire.com

CLARITEV STOCKHOLDER ALERT: Bragar Eagel & Squire, P.C. is Investigating Claritev Corporation on Behalf of Claritev Stockholders and Encourages Investors to Contact the Firm

02 Jun 2026, 23:53 PM
yahoo.com

Best Buy downgrade, Dell upgraded: Wall Street's top analyst calls

29 May 2026, 15:40 PM
globenewswire.com

CTEV INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Claritev Corporation

27 May 2026, 01:00 AM
yahoo.com

Sector Update: Healthcare Stocks Advance Late Afternoon

18 May 2026, 22:01 PM
yahoo.com

Sector Update: Healthcare Stocks Advance Monday Afternoon

18 May 2026, 19:57 PM
yahoo.com

Claritev Q1 Earnings Call Highlights

10 May 2026, 01:03 AM
yahoo.com

Claritev Corporation Q1 2026 Earnings Call Summary

07 May 2026, 22:45 PM
yahoo.com

Claritev Corporation (CTEV) Reports Q1 Loss, Tops Revenue Estimates

07 May 2026, 13:10 PM
yahoo.com

Clover Health Investments, Corp. (CLOV) Meets Q1 Earnings Estimates

07 May 2026, 00:30 AM
yahoo.com

Schrodinger, Inc. (SDGR) Reports Q1 Loss, Misses Revenue Estimates

06 May 2026, 00:05 AM
yahoo.com

How The Claritev (CTEV) Story Is Shifting As Analysts Trim Targets Yet Stay Positive

05 May 2026, 10:07 AM
yahoo.com

Concerns Surrounding AI Pressured Claritev Corp (CTEV)

21 Apr 2026, 17:27 PM
globenewswire.com

Claritev Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

25 Feb 2026, 03:54 AM
globenewswire.com

Camping World Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

25 Feb 2026, 03:48 AM
nasdaq.com

Claritev Slides 20% After Selling Stockholders Price 1.5 Mln Share Offering

13 Nov 2025, 19:27 PM
nasdaq.com

Claritev Corporation Q3 Loss Decreases

07 Nov 2025, 13:17 PM
yahoo.com

Claritev Corp (CTEV) Bounces to Revenue Growth as Net Loss Shrinks

25 Aug 2025, 06:08 AM
Market Cap
$577,569,539
Enterprise Value
$5,335,754,539
P/E
P/B
-1.96
P/S
0.58
EV / EBITDA
10.79
EV / Sales
5.36
EPS
-16.71
Dividend Yield
0%
P/FCF
P/CF
4.34
Free Cash Flow
-$17,924,000
ROE
96.11%
ROA
-5.94%
Debt / Equity
-16.2
Current Ratio
1
Quick Ratio
1
Cash
0.06
Avg Volume
$117,851
Fundamentals Snapshot Price
34.08

Income Statement

Line Item2026 Q22026 Q12025 Q42025 Q32025 Q2
Revenue257.48M244.68M246.55M245.96M241.57M
Cost of revenue67.67M69.08M70.09M62.06M60.82M
Gross profit189.81M175.6M176.46M183.9M180.75M
Operating income23.72M6.68M8.67M10.07M18.4M
EBITDA134.42M117.77M120.41M122.01M129.63M
Net income-59.23M-73.56M-80.57M-69.75M-62.64M
Income taxes-17.42M-19.16M-26.35M-23.61M-20.29M
Interest expense-100.25M-99.54M-99.41M-101.23M-99.75M
Other operating expenses00000
Total operating expenses166.09M168.92M167.79M173.83M162.35M
Basic EPS-3.49-4.41-4.87-4.23-3.81
Diluted EPS-3.49-4.41-4.87-4.23-3.81

Balance Sheet

Line Item2026 Q22026 Q12025 Q42025 Q32025 Q2
Total assets4.76B4.84B4.89B4.99B5.07B
Total liabilities5.05B5.07B5.06B5.09B5.11B
Total equity-287.84M-234.41M-167.18M-101.84M-39.91M
Cash & equivalents14.37M21.33M16.81M39.15M56.39M
Current assets236.42M242.27M224.37M257.46M247.14M
Current liabilities237.51M189.56M261.36M213.32M253.14M
Accounts payable56.67M59.18M60.46M38.93M43.43M
Receivables130.9M140.92M127.62M126.99M123.58M
Inventories00000
Goodwill2.41B2.41B2.41B2.4B2.4B
Long-term debt4.66B4.7B4.58B4.62B4.61B

Cash Flow

Line Item2026 Q22026 Q12025 Q42025 Q32025 Q2
Operating cash flow92.67M-45.78M66.29M19.86M61.24M
Investing cash flow-38.08M-46.77M-34.66M-22.87M-24.62M
Financing cash flow-61.64M98.93M-53.93M-13.63M-3.23M
Change in cash-7.05M6.39M-22.3M-16.64M33.39M
Net income-59.23M-73.56M-80.57M-69.75M-62.64M
KindFilingDateLink
edgar index4 — Claritev CorpView Filing
edgar index144 — Claritev CorpView Filing
form 4Form 4 — Misencik TiffaniView Filing
edgar index4 — Claritev CorpView Filing
edgar index144 — Claritev CorpView Filing
form 4Form 4 — Mintz William B.View Filing
edgar index8-K — Claritev CorpView Filing
edgar index10-Q — Claritev CorpView Filing
edgar index4 — Claritev CorpView Filing
edgar index4 — Claritev CorpView Filing
eight k text8-K — 8-KView Filing
form 4Form 4 — Garis Douglas MichaelView Filing
form 4Form 4 — Garis Douglas MichaelView Filing
form 4Form 4 — Garis Douglas MichaelView Filing
form 4Form 4 — Garis Douglas MichaelView Filing
form 4Form 4 — Garis Douglas MichaelView Filing
form 4Form 4 — Mintz William B.View Filing
edgar index8-K — Claritev CorpView Filing
eight k text8-K — 8-KView Filing
edgar index4 — Claritev CorpView Filing
form 4Form 4 — Albinson BrockView Filing
edgar index8-K — Claritev CorpView Filing
eight k text8-K — 8-KView Filing
edgar index4 — Claritev CorpView Filing
form 4Form 4 — Carol NutterView Filing
edgar index4 — Claritev CorpView Filing
edgar index4 — Claritev CorpView Filing
edgar index4 — Claritev CorpView Filing
form 4Form 4 — Prince John MichaelView Filing
edgar index8-K — Claritev CorpView Filing
eight k text8-K — 8-KView Filing
form 4Form 4 — Kim MichaelView Filing
form 4Form 4 — Dalton TravisView Filing
form 4Form 4 — Dalton TravisView Filing
form 4Form 4 — Dalton TravisView Filing
edgar index8-K — Claritev CorpView Filing
edgar index10-Q — Claritev CorpView Filing
edgar indexS-8 — Claritev CorpView Filing
eight k text8-K — 8-KView Filing
edgar index4 — Claritev CorpView Filing
edgar index4 — Claritev CorpView Filing
edgar index4 — Claritev CorpView Filing
edgar index4 — Claritev CorpView Filing
edgar index4 — Claritev CorpView Filing
edgar index4 — Claritev CorpView Filing
edgar index4 — Claritev CorpView Filing
edgar index8-K — Claritev CorpView Filing
eight k text8-K — 8-KView Filing
form 4Form 4 — HARRIS C MARTINView Filing
form 4Form 4 — Colaluca Anthony JrView Filing
form 4Form 4 — Colaluca Anthony JrView Filing
form 4Form 4 — Clarke Richard AView Filing
form 4Form 4 — Klein Michael StuartView Filing
form 4Form 4 — Klein Michael StuartView Filing
form 4Form 4 — Klapstein Julie DView Filing
form 4Form 4 — Prince John MichaelView Filing
form 4Form 4 — Kap Jason LamarView Filing
edgar index4 — Claritev CorpView Filing
form 4Form 4 — Albinson BrockView Filing
edgar indexDEF 14A — Claritev CorpView Filing
edgar indexDEFA14A — Claritev CorpView Filing
edgar indexARS — Claritev CorpView Filing
edgar index8-K — Claritev CorpView Filing
edgar index4 — Claritev CorpView Filing
edgar index4 — Claritev CorpView Filing
eight k text8-K — 8-KView Filing
form 4Form 4 — Garis Douglas MichaelView Filing
form 4Form 4 — Garis Douglas MichaelView Filing
form 4Form 4 — Garis Douglas MichaelView Filing
form 4Form 4 — Garis Douglas MichaelView Filing
form 4Form 4 — Garis Douglas MichaelView Filing
form 4Form 4 — Kim MichaelView Filing
edgar index4 — Claritev CorpView Filing
edgar index4 — Claritev CorpView Filing
edgar index4 — Claritev CorpView Filing